EUVIMEDSkopri EUVIMED
Crossref

The TRIM27 / STING Axis Mediates Schisandrin B‐Induced Inhibition of Myeloid‐Derived Suppressor Cells Accumulation to Potentiate Anti‐ PD ‐1 Immunotherapy in Hepatocellular Carcinoma

Lei Huang, Siying Li, Ziqing Li, Zhuo Qin, Yanan Sun, Caifang Qin, Chunmei Wang, He Li iD, Jinghui Sun, Jiping Wu, Zhihong Zhang iD

Phytotherapy Research · 2026-07 · 40 (7) · 4321-4345

DOI: 10.1002/ptr.70368 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-05-05. Written by Lei Huang and 10 co-authors. Institution: Department of Pharmacology, College of Pharmacy, Beihua University, Jilin, China. Major MEDLINE topics: Lignans, Polycyclic Compounds, Myeloid-Derived Suppressor Cells, Carcinoma, Hepatocellular. Cited 1 times so far (Crossref); 35 references. Funded by: Jilin Province Science and Technology Development Plan Project, Innovative Research Group Project of the National Natural Science Foundation of China, Beihua University Doctoral Research Fund Project.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Hepatocellular carcinoma (HCC) is characterized by a highly immunosuppressive microenvironment, which contributes to its unfavorable clinical outcomes. Myeloid‐derived suppressor cells (MDSCs) play a crucial role in this process. Schisandrin B (SchB) shows anti‐tumor potential, but its mechanism in suppressing MDSCs remains unclear. This study investigates how SchB inhibits MDSCs accumulation and enhances anti‐PD‐1 therapy efficacy in HCC.SchB's efficacy and mechanism were investigated both in vitro and in vivo. In vitro, MTT, wound healing, EdU, colony formation, flow cytometry, ELISA, western blot, immunofluorescence, Co‐IP, molecular dynamics (MD), and CETSA assays were employed to evaluate the therapeutic effects and mechanistic action of SchB on HCC. In vivo, a mouse HCC xenograft model was used to evaluate whether SchB could enhance the anti‐tumor effect of PD‐1 mAb and the potential mechanism.Mechanistically, SchB suppressed TRIM27 expression, disrupted the interaction between TRIM27 and STING, and enhanced STING/TBK1/IRF3 signaling, thereby suppressing the secretion of IL‐6 and GM‐CSF as well as the accumulation of MDSCs. SchB could directly bind to TRIM27 and downregulate its expression, thereby enhancing STING protein stability. In vivo , SchB effectively reduced MDSCs accumulation while promoting T cell recruitment, thereby augmenting the antitumor efficacy of PD‐1 mAb therapy.SchB up‐regulates STING by suppressing TRIM27, inhibits IL‐6/GM‐CSF secretion, and reduces MDSCs accumulation, indicating that SchB has the potential to be a promising candidate for PD‐1 inhibitor therapy in HCC.

Subjects

MeSH terms (MEDLINE)

LignansPolycyclic CompoundsMyeloid-Derived Suppressor CellsCarcinoma, HepatocellularMembrane ProteinsLiver NeoplasmsDNA-Binding ProteinsAnimalsCyclooctanesHumansMiceSTING ProteinCell Line, TumorProgrammed Cell Death 1 ReceptorSignal TransductionImmunotherapyTripartite Motif ProteinsMaleXenograft Model Antitumor AssaysMice, Inbred BALB CcGAS-STING Signaling PathwayUbiquitin-Protein Ligases

Author keywords

MDSCsSTINGSchBTRIM27hepatocellular carcinoma

Substances

LignansPolycyclic CompoundsCyclooctanesMembrane Proteinsschizandrin BSTING ProteinProgrammed Cell Death 1 ReceptorSting1 protein, mouseTripartite Motif ProteinsDNA-Binding Proteins

Authors and institutions

  • Department of Pharmacology, College of Pharmacy, Beihua University, Jilin, China.
  • Department of Immunology, School of Basic Medicine, Beihua University, Jilin, China.

ORCID profiles: He Li, Zhihong Zhang

Funding

  • Jilin Province Science and Technology Development Plan Project
  • Innovative Research Group Project of the National Natural Science Foundation of China
  • Beihua University Doctoral Research Fund Project
  • Beihua University Youth Research and Innovation Team
  • Beihua University Graduate Innovation Project
  • Education Department of Jilin Province Project
  • National Natural Science Foundation of China

Cite

APA

Huang, L., Li, S., Li, Z., Qin, Z., Sun, Y., Qin, C., Wang, C., Li, H., Sun, J., Wu, J., & Zhang, Z. (2026). The TRIM27 / STING Axis Mediates Schisandrin B‐Induced Inhibition of Myeloid‐Derived Suppressor Cells Accumulation to Potentiate Anti‐ PD ‐1 Immunotherapy in Hepatocellular Carcinoma. Phytotherapy Research, 40(7), 4321-4345. https://doi.org/10.1002/ptr.70368

Vancouver

Huang L, Li S, Li Z, Qin Z, Sun Y, Qin C, et al. The TRIM27 / STING Axis Mediates Schisandrin B‐Induced Inhibition of Myeloid‐Derived Suppressor Cells Accumulation to Potentiate Anti‐ PD ‐1 Immunotherapy in Hepatocellular Carcinoma. Phytotherapy Research. 2026;40(7):4321-4345. doi:10.1002/ptr.70368

BibTeX
@article{Huang2026,
  author = {Huang, Lei and Li, Siying and Li, Ziqing and Qin, Zhuo and Sun, Yanan and Qin, Caifang and Wang, Chunmei and Li, He and Sun, Jinghui and Wu, Jiping and Zhang, Zhihong},
  title = {The TRIM27 / STING Axis Mediates Schisandrin B‐Induced Inhibition of Myeloid‐Derived Suppressor Cells Accumulation to Potentiate Anti‐ PD ‐1 Immunotherapy in Hepatocellular Carcinoma},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {7},
  pages = {4321--4345},
  doi = {10.1002/ptr.70368}
}
Start for free →